IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

January 15, 2025 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery.

NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards' Brand Leadership category for its "Timing is Everything" campaign. The campaign features IFF's newly designed controlled release platform, which provides customers with solutions at every turn.

This award recognizes "Timing is Everything" campaign for its strategic marketing tactics, creativity and leadership. The campaign focuses on building an integrated thought leadership platform for controlled release through storylines and cohesive branding. It includes a three-pronged approach with a social media teaser countdown, video and microsite.

"We are honored to receive this esteemed recognition for our 'Timing is Everything' campaign that highlights our controlled release portfolio," said Lisa M. Miree-Luke, global communications director, IFF Pharma Solutions. "This award is a testament to our trailblazing products and the passionate teams behind them. METHOCEL™─Pioneering Then, Innovating Now; ETHOCEL™─Proven Time After Time and POLYOX™─Versatile Across Complex and Unique Applications, they are not just taglines but promises we stand by. We are committed to driving innovation, quality and helping to enable our customers' successes."

The "Timing is Everything" campaign elevates brand awareness and culminates in the creation of a best-in-class dedicated thought leadership platform for controlled release polymers in the excipients industry. The platform educates visitors about pharmaceutical formulations that benefit patients and the importance of controlled release of active ingredients through comprehensive materials such as white papers, webinars and articles.

The Pharmaceutical Technology Excellence Awards honors the most significant achievements and innovations in the pharmaceutical industry. Powered by GlobalData's business intelligence, the awards recognize the people and companies leading change and shaping the future of the industry.

###

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.comLinkedInInstagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Emily Kaufman
Global Communications Specialist
+1 9086705691
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.